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doi:10.1016/j.ejvs.2010.10.008Abstract Introduction: Fenestrated aortic stent-grafts are increasingly being used to treat
patients with juxtarenal abdominal aortic aneurysms (AAA). Sizing of these stent-grafts is crit-
ical to ensure success and requires detailed expert assessment of aortic morphology. At
present little is known about how sizing of these stent-grafts varies between observers and
the necessary tolerances involved to ensure a successful procedure.
Methods: CT scans of 19 consecutive patients with juxtarenal aortic aneurysms that underwent
successful endovascular repair with fenestrated stent-grafts were selected. Sizing of fenes-
trated aortic stent-grafts was performed independently by four experienced endovascular
surgeons and results were compared. Data from the stent-graft manufacturer was available
for comparison in 12 cases.
Results: All observers agreed on the number of fenestrations; 16 devices had 3 fenestrations and 3
had 4. The overall inter-observer measurement error for all target vessel orientation was 12.6
(10.8e14.4 95% CI), and for distance between target vessels 5.3 mm (4.4e6.2 95% CI). The
median difference in internal stent-graft diameter was 1 stent size. Agreement on fenestration
type ranged from (84e95%). Comparison was performed with the manufactured stent-graft in 12
cases.Theoverallmeandifferenceof targetvessel orientationbetween themanufactureddevices
and the four observers was1.3 (SD 6.9,3.8e1.2 95% CI). There was less agreement between
observers and device manufacturers on body and limb lengths and distal limb diameters.
Conclusions: There was generally a high level of agreement between experienced endovascular
surgeons in sizing the fenestrated stent component. Therewere differences in component lengths
but these could have been accommodated by varying the degree of overlap between components.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.87252816.
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Figure 1 a: Proximal stent showing scallop for the SMA and
two fenestrations for the renal arteries. b: Fenestrated stent-
graft components with corresponding lengths and diameters
used for device planning. Proximal graft diameter (D1), prox-
imal graft length (L1), distal body length (L2), ipsilateral limb
length (L3), contralateral limb length (L4), ipsilateral limb
diameter (D3) and contralateral limb diameter (D4).
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Fenestrated aortic stent-grafts are increasingly being used to
treat juxtarenal abdominal aortic aneurysms (AAA) as
outcomes appear favourable when compared with open sur-
gery.1e3 However, there are limitations of this new technique,
including high treatment costs, delay in manufacturing
a custom made device, availability and complexity.4 The
techniques’success depends critically uponappropriate sizing
of the stent-graft to ensure aneurysm exclusion and mainte-
nance of visceral branch perfusion.4e6 This process is labour
intensive and has in the majority of cases been performed by
the manufacturer in a centralized planning facility. These
issues contribute to the expense of the technique, treatment
delay and potentially limit its more widespread application.
Current aortic stent-graft technology houses the fenes-
trations for visceral vessel perfusion in a single tubular
component which is the proximal part of a modular bifur-
cated system (Zenith Fenestrated, Cook Medical, Brisbane,
Australia) Fenestrations may be in the form of scallops,
large or small fenestrations (Fig. 1a). Accurate determina-
tion of visceral branch orientation (clock face position or
orientation angle) and displacement from proximal stent-
graft edge and other visceral branches is essential to obtain
a satisfactory result.5,6
At present, little is known about the differences and
implications of sizing aortic stent-grafts between different
specialists and between clinicians and the manufacturer.
This study investigates the variability in planning endovas-
cular aneurysm repair using fenestrated stent-grafts by
appropriately trained experienced endovascular specialists
working independently in different institutions and
compares them with industry measurements.
Methods
Computed tomography scans of 19 consecutive patients
with juxtarenal aortic aneurysms that underwent successful
endovascular repair with a fenestrated aortic stent-graft
(Zenith Fenestrated, Cook Medical, Brisbane, Australia)
were selected for this study. Preoperative CT aortic
protocol was performed for all patients (GE Lightspeed
VCT, GE Healthcare, WI, USA) with iodinated contrast
(Omnipaque 350, Nycomed Amersham, NJ, USA) injected at
4 ml/s (SmartPrep, GE Healthcare). Axial images were
acquired at 0.625 mm intervals.
Morphological measurement and planning
Four vascular surgeons (TR, MB, BM, and RH) with experience
in fenestrated EVAR and planning from four different insti-
tutions were asked to independently assess and plan fenes-
trated aortic stent-grafts. Each author was provided with
a digital versatile disc (DVD) of anonymised CT scans and
a standardised proforma. Specific guidance on obtaining
measurements was deliberately avoided and observers were
asked to obtain measurements and plan stent-grafts as they
would in their routine clinical practice. Three dimensional
reconstruction software was used by all observers. Briefly,
digital imaging and communications in medicine (DICOM)
files were imported into a 3D workstation and with the aid ofa workflow assistant, the aorta was segmented, bony skel-
eton excluded and a centre lumen line defined in preparation
for measurement. Tera Recon software (Tera Recon Inc., San
Mateo, CA, USA.) or 3mensio Vascular (3Mensio Medical
Imaging, Bilthoven, The Netherlands) was used.
Surgeons were asked to assess the morphology of the
aneurysmand thenplan a suitable standard fenestrated aortic
stent-graft. Measurements performed (Fig. 1b) included the
internal aortic stent-graft diameter (D1), number of internal
(sealing) stents, and number of fenestrations. Target vessel
orientation (clock face position then converted to degrees for
analysis considering 12 O’clock as 0, the angle of each target
vesselwasmeasured relative toother targetvessels), distance
from the bottom edge of the coeliac axis and fenestration size
(scallop, large or small). Proximal and distal body lengths and
diameters were also collected. Proximal graft length (L1),
distal body length (L2), ipsilateral limb length (L3), contra-
lateral limb length (L4), ipsilateral limb diameter (D3) and
contralateral limb diameter (D4). In addition, in 12 cases,
device planning data was obtained from the stent-graft
manufacturer and compared with measurements and recom-
mendations from the 4 observers.
Figure 2 Inter-observer measurement error of target vessel
orientation showing means and 95% confidence intervals. (CA,
Coeliac axis, SMA, superior mesenteric artery, LRA and RRA,
left and right renal arteries respectively).
Figure 3 (Anatomical) distribution of target vessel orienta-
tion in degrees. Showing mean and SD.
Sizing Fenestrated Aortic Stent-grafts 313Statistical analysis
Data were collected, entered into a database and analyzed
(GraphPad Prism 5, GraphPad Software, Inc. CA, USA).
Inter-observer variability for continuous variables was
expressed as inter-observer measurement error and 95%
confidence interval. The measurement error was calculated
from the mean standard deviation of the difference in
measurement as performed by the four observers per target
vessel for orientation (difference of angle between each
target vessel) and distance and averaged for all patients.
Comparison with manufactured device data was expressed
as the mean difference in measurement, standard devia-
tion (SD) and 95% confidence interval.
For discreet variables, median and range were used to
express inter-observer variability. Orientation was repre-
sented in degrees () and distance between coeliac axis (CA),
superior mesenteric artery (SMA), left and right renal
arteries (LRA, RRA respectively) in mm. One way analysis of
variance (ANOVA) was used to detect any significant differ-
ence between target vessel orientationmeasurements (SMA,
LRA andRRA) and distance betweenCA, SMA, LRA andRRA. In
12 cases the resultant values were also compared with
available data from thatwhichwas designed from the central
planning facility of the stent-graft manufacturer.
Results
Computed tomography image quality
CT image quality was considered satisfactory for 3 dimen-
sional reconstruction in 96% (73/76) of occurrences.
Although scan quality was considered suboptimal in the
remaining 3, this did not preclude performing the
measurements and stent-graft planning.
Inter-observer variability in morphological
assessment and stent-graft planning
Aortic morphology
Number of fenestrations. All observers agreed on the
number of fenestrations for each case; 16 devices had 3
fenestrations and the remainder had 4 fenestrations.
Target vessel orientation. 60 target vessels were analysed
for agreement between observers regarding target vessel
orientation. The overall inter-observer measurement error
for all target vessel orientation was 12.6 (10.8e14.4 95%
CI). The inter-observer measurement error of the orienta-
tion of the CA was 11.4 (6.7e16.0 95% CI); for the SMA
10.1 (7.5e12.6 95% CI); for the LRA 15.8 (12.4e19.2
95% CI); and for the RRA 13.4 (9.6e17.3 95% CI) (Fig. 2).
There was no significant variance in the difference in
measurement of target vessel orientation between CA,
SMA, LRA ad RRA (ANOVA, P Z 0.13).
The anatomical distribution of target vessel orientation
as measured by the four observers (mean angle) for the CA,
SMA, LRA and RRA was 18, 4, 80 and 67 (Fig. 3).
Distance between target vessels. The overall inter-observer
measurement error between observers for distance betweentarget vessels was 5.3 mm (4.4e6.2 95% CI). The inter-
observer error in measurement of the distance from CA to
SMA, RRA and LRA was 5.0 mm (3.5e6.5 95% CI), 4.4 mm
(3.2e5.6 95% CI) and6.4 mm (4.4e6.2 95% CI) respectively
(Fig. 4). Variance between differences inmeasurement of all
distances (CA-SMA, SA-LRA and CA-RRA) was not significant
(ANOVA, pZ 0.19).
The mean distance as measured by the four observers
between CA-SMA, CA-LRA and CA-RRA was 21 mm, 31 mm
and 35 mm respectively (Fig. 5).
Proximal stent diameter and component number. All
observers selected 2 internal stents. The median difference
in internal stent-graft diameter was 1 stent size (Inter
quartile range 0e2 stent sizes, one stent size Z 2 mm
difference). The maximum difference between observers
was 4 stent sizes.
Allocation of target vessel fenestration. There was
universal agreement for a scallop for the coeliac axis. 64
allocations (84%) (64/76) were for a scallop to the SMA with
the rest (16%) allocating a large fenestration. Observers
agreed on fenestration type for the SMA in 84% of cases.
Figure 4 Inter-observer measurement error of the distance
between CA and SMA, LRA and RRA, showing means and 95%
confidence intervals.
Figure 6 Frequency distribution of the deviation of
measured internal stent diameters from actual manufactured
stent-graft diameters.
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cases.
As for the renal arteries, there was agreement in allo-
cation in 94% of allocations for the left renal and 95% (72/
76) of the time for the right renal. The majority of fenes-
trations allocated for the renal arteries were small fenes-
trations (97%).
Agreement with manufactured device
Target vessel fenestrations
The overall mean difference of target vessel orientation
between the manufactured devices and the four observers
was1.3 (SD 6.9,3.8e1.2 95% CI). Themean difference
for the SMA was 2.6 (SD  8.0, 8.0e2.7 95% CI). For the
LRA and RRA 2.3 (SD  4.8, 1.1e5.7 95% CI) and 3
(SD  6.8, 7.3e1.2) (Fig. 7). There was no significant vari-
ance in the mean difference between the target vessels and
the manufactured devices for the four target vessels
measured (CA, SMA, LRA and RRA) (ANOVA, pZ 0.15).
Allocation of fenestration size
For the SMA, there was concordance with the manufactured
device in 83% of allocations for fenestration size (scallop,Figure 5 Distribution of distance (mm) between CA and SMA,
LRA and RRA. Scatter plot showing mean distance, error bars
represent standard deviation.large or small, 40/48). The disagreement between
observers and manufactured stent-grafts where, allocating
scallop where the actual device was a fenestration for SMA
in 7 cases and 1 where fenestration was suggested and
a scallop was actually made.
There was higher agreement between observers in
allocating fenestrations for the left and right renal arteries
(mainly small fenestrations, 94% and 95% of cases
respectively).
Internal stent diameter
The interquartile range (IQR) for the difference in internal
stent diameter stent size between the observers and the
manufacturer was 2. This ranged from undersizing to
oversizing by one stent size in each direction (1 to 1 stent
size difference). The maximum difference was 4 stent sizes
(Fig. 6).
Stent-graft component lengths and distal limb diameters
The interquartile range of the difference in measurement
between observers and manufacturer was 1 for both the
ipsilateral limb diameter (D3) and contralateral limb
diameter (D4) with a tendency of the observers to under-
size compared to the manufacturer (IQR 0 to 1 stent size).
As for the proximal graft length (L1), the interquartile
range was 2. For the distal body length (L2), ipsilateral limb
length (L3) and contralateral limb length (L4), the inter-
quartile range was 1. There was a tendency to oversize by
the observers compared to the manufacturer particularlyFigure 7 Mean difference and 95% confidence interval
between observer target vessel orientation and manufactured
stent-graft. (0 Z agreement with manufacturer).
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(Fig. 8).
Discussion
To investigate the level of agreement in morphological
assessment and device planning for juxtarenal aneurysms,
four experienced observers in four different institutions
performed morphological assessment and planned fenes-
trated devices independently as they would do in their
normal clinical practice. A standard proforma was provided
but specific methodology to obtain these measurements
was intentionally avoided to simulate “real world” routine
clinical practice.
At first glance, there appears to be little agreement
between observers on target vessel orientation (angle) with
only 7% of all angles being chosen by all the four observers.
On closer examination, the variability in measurement as
expressed by the inter-observer measurement error was
slight. This was lowest for SMA (10). The highest vari-
ability was for LRA, but this was only just over 15. There is
no consensus regarding maximum tolerance levels in clin-
ical practice between fenestration orientation and target
vessel orientations. Some experienced endovascular
specialists have suggested that a tolerance level of 15 was
considered acceptable as a smaller difference between
fenestration and target vessel is unlikely to lead to a clini-
cally significant event.7 Despite using different worksta-
tions and sizing methodology, the overall inter-observer
error was less than the suggested level of tolerance of 15.
All observers selected 2 internal stents. This may reflect
the guidance from stent-graft manufacturers as having 2
internal stents potentially offers better seal and more
flexibility in positioning the fenestration. There was
agreement on internal stent diameter in 21% of cases (16/
76). The median inter-observer difference in internal stent
diameter was 1 stent size. With a total of 58% of internal
stent diameter measurements differing by only one stent
size which is considered by some a clinically acceptable
variation.7,8 It would be expected that the agreement
would be higher for the internal stent-graft diameter. On
further examination of the frequency distribution, the
difference was 2 stents or less in 75% of cases. This would
translate into a difference of the internal stent diameter by
4 mm.Figure 8 Difference between observer recommendations for
distal body length (L2), ipsilateral and contralateral limb
length (L3, L4) and manufactured stent-graft. (median and
range, 0 Z agreement with manufacturer).A comparison between the devices planned by the four
observers and actual manufactured devices is useful.
Recently there has been interest in developing “off the
shelf” fenestrated stent-grafts that would be stored in
central repositories containing a finite number of fenes-
trated devices that would enable treatment of the majority
of patients with juxtarenal aneurysms.7,9
It is important then to assess the degree of variability in
planning as performed by different experienced operators.
The overall mean difference of target vessel orientation
between the manufactured devices and the four observers
was 1.3 (SD  6.9).There was concordance with target
vessel orientation as per the manufactured device in 35% of
measurements. However, 94% of target vessels where
within 15 of the fenestration eventually manufactured
with only 6% falling outside this range (Table 1).
The observers’ recommendations for the internal stent
diameter agreed with those of the manufacturer in 38% of
measurements. With another 35% being within one stent
size. This left only 27% of measurements outside the
tolerance range. As for allocating fenestration type, there
was agreement with the manufactured devices in 83% of
cases when allocating a fenestration type for the SMA and
a higher percentage (94e95%) for renal arteries.
As expected, there was less agreement in distal device
lengths and diameters between observers and the manu-
facturer (Fig. 8). This reflects individual preferences on
main body and limb lengths. Some would prefer longer main
body with shorter limb lengths. This becomes more variable
when the degree of overlap is also considered.
Case selection for this study was for patients who
underwent successful endovascular repair of juxtarenal
aneurysms with fenestrated stent-grafts that would have
been unsuitable candidates for repair with a standard
stent-graft. CT scans of patients with suprarenal aneurysms
and morphology that would pose a relative contraindication
by some for repair with a fenestrated device such as
a severely angulated or no infrarenal neck were excluded.
So there would be no surprise that all observers agreed on
the number of fenestrations for each case. However, in
respect of all other measurements and planning, observers
used different workstations in different institutions and
were blinded to the actual device that was manufactured.
Ideally a larger number of cases would have been
desirable, but was prohibited in part due to the strict
inclusion criteria, excluding any patient with equivocal
morphology or suboptimal CT scans needed for the
different workstations. Also, performing a detailed
morphological assessment and planning fenestrated stent-
grafts is complex and time consuming in some cases
compared to endovascular planning for infrarenal aneu-
rysms. Obtaining manufacturer planning data for all cases
would have been desirable, but it was only possible toTable 1 Agreement with manufactured device for target
vessel orientation.
Agreement (%) 15 (%) >15 (%)
SMA 20 (42) 24 (50) 4 (8)
LRA 14 (29) 26 (54) 4 (8)
RRA 15 (31) 32 (67) 1 (2)
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turer for 12 cases.
Accuracy is essential in planning fenestrated endovas-
cular aneurysm repair.5,6 The use of 3 dimensional work-
stations has made this task easier but there are still some
concerns over intra and inter-observer variability.8,10,11
Recently, it has been shown that this problem is signifi-
cant in a small percentage of patients.12 Standardisation of
terminology relating to juxtarenal aneurysms is lacking
currently and may improve the communication of results
and act as a guide in treatment.
It is still notentirely clear if the tolerance limits referred to
above are over constrictive or too lax. Early in the experience
with fenestrated stent-grafts, planning was performed using
axial CT images that don’t accurately represent in vivo vessel
orientation, with satisfactory results. Aortic morphology is
altered during the cardiac cycle, and as cardiac gated CT is
not widely used in routine practice this effect is currently
ignored on standard CT imaging.13 Furthermore, insertion of
stiff wires and the aortic stent-graft will change the native
morphology.8,11 It is also likely that with the development of
more advanced, low profile flexible stent-grafts, that
a greater degree of flexibility could be accepted.
Endovascular repair with fenestrated stent-grafts is
associated with lower perioperative morbidity and mortality
compared to open surgery.3,14,15 Data on medium term
durability and target vessel patency is favourable and long-
term outcomes are awaited.1,2 The custom made nature of
these devices has so far limited their applicability due cost
and the necessary delay in manufacture.
The concept of central repositories of readymade off the
shelf fenestrated devices is gaining interest and looks like
a potentially realistic prospect in the near future.7,9 This
might make fenestrated technology available to more
patients, particularly those with emergency presentation,
and will reduce cost. With solutions to increase applicability
on the horizon, it would seem logical for appropriately
trained endovascular specialists in regional centres to be
able to size and plan fenestrated stent-grafts.7,9 Not only to
decrease the time lag tomanufacture but also, potentially to
be able to choose suitable fenestrated stent-grafts “off the
shelf” thus offering this modality in the emergency setting
and for those who are at risk of rupture and cannot wait for
the current 6e8 weeks time required for customisation.
In conclusion there was an overall high level of agree-
ment both between observers and the stent-graft manu-
facturer in the majority of cases. This is despite the fact
that the observers preformed the measurements indepen-
dently, in different institutions using different methods of
assessing morphology and planning.
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